Emami Limited EMAMILTD NIFTY_SMALLNSE
Emami Limited manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic cream, body lotion, prickly heat powder, petroleum jelly, soaps, aloe vera gel, and all-season cream under the BoroPlus brand; oil and cool talc products under the Navratna brand; and ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as healthcare products comprising hair growth vitalizers, skin elixirs, organic apple cider vinegar, cough syrup, herbal tea, health juices, honey, and herb tablets under the Zandu brand. It also provides oils, conditioners, shampoos, and ayurvedic capsules under the Kesh King brand; brightening creams, and brightening and oil clear face washes for men under the Smart And Handsome brand; balms under the Mentho Plus brand; hair oils under the Emami 7 Oils in One brand; prickly heat powders under the Dermicool brand; moisturising creams and body lotions under the Creme 21 brand; deodorants, eau de toilettes, shampoos, face washes, and shower gels under the HE brand; and body sprays and perfumes, beard and shaving products, body and hair care products, face washes, gift sets, and tools and accessories under The Man Company brand. In addition, the company offers face serums, oil shots, powder face washes, and hair and pure oils under the Brillare brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; cold cream under the Emami Malai Kesar Cold Cream brand; and deep moisturizing cream under the Emami Pure Glow brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Strong return on equity of 27.6%.
- Healthy ROCE of 28.6%.
- Excellent profit margin of 20.5%.
- Attractive dividend yield of 3.01%.
- Generates positive free cash flow.
CONS
- Trading 35.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | EMAMILTD Emami Limited NIFTY_SMALLNSE | 399.10 | 22.47 | ₹17,420.72 Cr | 3.01% | 28.59% | 27.61% | 3.98% | 6.62% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,153.50 | 47.62 | ₹5.06 L Cr | 2.04% | 22.15% | 21.60% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 286.90 | 17.39 | ₹3.59 L Cr | 5.58% | 36.47% | 29.34% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,421.50 | 78.10 | ₹2.74 L Cr | 0.84% | 59.30% | 76.34% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 4,054.50 | 88.49 | ₹2.64 L Cr | - | 16.41% | 12.94% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 528.00 | 56.17 | ₹1.79 L Cr | 0.38% | 19.44% | - | 17.26% | 26.57% |
| 7 | TATACONSUM Tata Consumer Products Limited NIFTY50NSE | 1,178.40 | 75.78 | ₹1.17 L Cr | 0.85% | 8.29% | 6.94% | 13.87% | 8.61% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 821.70 | 60.60 | ₹1.06 L Cr | 0.49% | 39.00% | 41.39% | 12.00% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,029.30 | 56.49 | ₹1.05 L Cr | 1.94% | 21.44% | 15.10% | 4.59% | 3.02% |
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 963.05 Cr | 904.09 Cr | 798.51 Cr | 1,151.81 Cr | 925.10 Cr |
| Cost of Revenue | - | - | 328.43 Cr | 276.46 Cr | 231.37 Cr | 338.26 Cr | 291.92 Cr |
| Gross Profit | - | - | 634.62 Cr | 627.63 Cr | 567.14 Cr | 813.55 Cr | 633.18 Cr |
| Operating Expenses | - | - | 458.71 Cr | 457.91 Cr | 433.88 Cr | 474.67 Cr | 488.73 Cr |
| Operating Income | - | - | 175.91 Cr | 169.72 Cr | 133.26 Cr | 338.88 Cr | 144.45 Cr |
| EBITDA | - | - | 240.01 Cr | 233.70 Cr | 198.08 Cr | 393.29 Cr | 209.47 Cr |
| Interest Expense | - | - | 2.78 Cr | 2.43 Cr | 2.63 Cr | 2.92 Cr | 3.15 Cr |
| Pretax Income | - | - | 193.70 Cr | 186.77 Cr | 150.18 Cr | 345.05 Cr | 164.07 Cr |
| Tax Provision | - | - | 31.53 Cr | 22.51 Cr | 1.83 Cr | 25.57 Cr | 20.90 Cr |
| Net Income | - | - | 162.17 Cr | 164.26 Cr | 148.35 Cr | 319.48 Cr | 143.18 Cr |
| Diluted EPS | - | - | 3.72 | 3.76 | 3.40 | 7.32 | 3.28 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 3,362.01 Cr | 3,530.27 Cr | 3,809.19 Cr | 3,779.51 Cr |
| Cost of Revenue | - | 1,223.77 Cr | 1,182.14 Cr | 1,194.23 Cr | 1,138.01 Cr |
| Gross Profit | - | 2,138.24 Cr | 2,348.13 Cr | 2,614.96 Cr | 2,641.50 Cr |
| Operating Expenses | - | 1,522.73 Cr | 1,582.69 Cr | 1,768.06 Cr | 1,855.19 Cr |
| Operating Income | - | 615.51 Cr | 765.44 Cr | 846.90 Cr | 786.31 Cr |
| EBITDA | - | 924.19 Cr | 986.72 Cr | 1,081.41 Cr | 1,034.54 Cr |
| Interest Expense | - | 7.39 Cr | 9.98 Cr | 9.34 Cr | 11.13 Cr |
| Pretax Income | - | 669.55 Cr | 790.83 Cr | 893.86 Cr | 846.07 Cr |
| Tax Provision | - | 42.14 Cr | 66.70 Cr | 91.12 Cr | 70.81 Cr |
| Net Income | - | 639.57 Cr | 723.53 Cr | 806.46 Cr | 775.27 Cr |
| Diluted EPS | 18.88 | 14.50 | 16.55 | 18.48 | - |
Compounded Sales Growth
| 5 Years: | 3.98% |
| 1 Year: | -3.90% |
Compounded Profit Growth
| 5 Years: | 6.62% |
| 1 Year: | -11.80% |
Stock Price Performance
| 1 Year: | -30.72% |
| 6 Months: | -21.66% |
| 3 Months: | -15.93% |
| 1 Month: | -10.21% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 3,109.85 Cr | 3,279.70 Cr | 3,533.63 Cr | 3,836.44 Cr |
| Current Assets | - | 1,286.81 Cr | 1,418.22 Cr | 1,733.66 Cr | 1,934.86 Cr |
| Cash & Equivalents | - | 46.78 Cr | 52.95 Cr | 104.63 Cr | 176.75 Cr |
| Inventory | - | 328.04 Cr | 323.40 Cr | 308.10 Cr | 399.57 Cr |
| Receivables | - | 414.60 Cr | 494.21 Cr | 451.29 Cr | 343.32 Cr |
| Total Liabilities | - | 797.09 Cr | 821.99 Cr | 840.27 Cr | 914.00 Cr |
| Current Liabilities | - | 723.89 Cr | 758.83 Cr | 779.35 Cr | 838.24 Cr |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 90.51 Cr | 93.96 Cr | 89.79 Cr | 161.92 Cr |
| Total Equity | - | 2,302.80 Cr | 2,446.59 Cr | 2,694.79 Cr | 2,923.98 Cr |
| Shares Outstanding | - | 44.12 Cr | 43.65 Cr | 43.65 Cr | 43.65 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 748.88 Cr | 779.01 Cr | 895.88 Cr | 800.53 Cr |
| Investing Cash Flow | - | -112.83 Cr | -205.40 Cr | -340.15 Cr | -181.14 Cr |
| Financing Cash Flow | - | -607.64 Cr | -562.97 Cr | -499.61 Cr | -554.49 Cr |
| Capital Expenditure | - | -40.46 Cr | -40.59 Cr | -44.57 Cr | -43.32 Cr |
| Free Cash Flow | - | 708.42 Cr | 738.42 Cr | 851.31 Cr | 757.21 Cr |
| Net Change in Cash | - | 28.40 Cr | 10.64 Cr | 56.12 Cr | 64.90 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 63.6% | 66.5% | 68.6% | 69.9% |
| Operating Margin % | - | 18.3% | 21.7% | 22.2% | 20.8% |
| Net Margin % | - | 19.0% | 20.5% | 21.2% | 20.5% |
| ROE % | - | 27.8% | 29.6% | 29.9% | 26.5% |
| ROCE % | - | 25.8% | 30.4% | 30.7% | 26.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EMAMILTD